Skip to main content
Premium Trial:

Request an Annual Quote

Sophia Genetics Q4 Revenues up 40 Percent on Bioinformatics Platform Sales

NEW YORK — Sophia Genetics on Tuesday reported a 40 percent year-over-year jump in revenues for the fourth quarter on growing demand for its bioinformatics platform.

For the three-month period ended Dec. 31, 2021, Sophia's revenues were $10.9 million, up from $7.8 million the year before. During Q4, platform analysis volumes increased 50 percent to roughly 66,000 from 44,000 in the year-ago quarter, the firm said.

The company's net loss in the fourth quarter grew to $21.4 million, or $.33 per share, from $10.5 million, or $.22 per share, in the same period in 2020. Analysts had, on average, been expecting a loss per share of $.36.

R&D spending in the fourth quarter was up 23 percent to $6.4 million from $5.2 million, while SG&A costs nearly doubled to $21.5 million from $11.1 million year on year.

At the end of 2021, Sophia, which raised $234 million in an initial public offering in mid-2021, had about $193.0 million in cash and cash equivalents.

For the full-year 2021, Sophia's revenues climbed 43 percent to $40.5 million from $28.4 million the year before but fell short of the Wall Street consensus estimate of $40.9 million. Sophia attributed the revenue growth to new customers added to its platform along with increased usage rates by existing customers. The Saint-Sulpice, Switzerland- and Boston-based company noted that total recurring platform customers grew to 382 as of Dec. 31, compared with 314 at the end of 2020.

Sophia's full-year 2021 net loss jumped to $73.7 million, or $1.33 per share, from $39.3 million, or $.93 per share, in 2020.

Its R&D expenses in 2021 were up 43 percent to $26.6 million from $18.6 million a year earlier, as its SG&A costs rose 93 percent to $70.2 million from $36.4 million the previous year.

Looking ahead, Sophia said that it expects full-year 2022 revenues to be in the range of $51.5 million and $54 million.

During early morning trading on the Nasdaq, shares of Sophia were up $.22 at $9.31.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.